Stockscreener 앱 받기
1.33
0.76%
0.01
시간 외 거래:
1.33
Werewolf Therapeutics Inc 주식(HOWL)의 최신 뉴스
Smart tools for monitoring Werewolf Therapeutics Inc.’s price actionRate Cut & Verified Momentum Watchlists - Newser
What recovery options are there for Werewolf Therapeutics Inc.2025 Earnings Surprises & Stepwise Trade Signal Implementation - Newser
When is the best time to exit Werewolf Therapeutics Inc.Stop Loss & High Conviction Investment Ideas - Newser
Is Werewolf Therapeutics Inc. backed by strong institutional buyingWeekly Earnings Recap & Smart Investment Allocation Insights - sundaytimes.kr
Using data models to predict Werewolf Therapeutics Inc. stock movementJobs Report & Technical Pattern Based Buy Signals - Newser
Using data filters to optimize entry into Werewolf Therapeutics Inc.Recession Risk & Trade Opportunity Analysis - Newser
Is Werewolf Therapeutics Inc. meeting your algorithmic filter criteriaTrend Reversal & Weekly Setup with High ROI Potential - Newser
Real time alert setup for Werewolf Therapeutics Inc. performanceMarket Activity Summary & Real-Time Sentiment Analysis - Newser
Werewolf Therapeutics reports Q2 EPS (40c), consensus (37c) - MSN
Werewolf Therapeutics Reports Q2 2025 Financial Results - MSN
Werewolf Therapeutics Inc. stock momentum explained2025 Key Lessons & Weekly Breakout Stock Alerts - Newser
Published on: 2025-08-15 16:22:03 - Newser
Custom watchlist performance reports with Werewolf Therapeutics Inc.Price Action & Stepwise Entry/Exit Trade Alerts - Newser
Can swing trading help recover from Werewolf Therapeutics Inc. lossesQuarterly Trade Report & AI Forecasted Entry and Exit Points - Newser
Werewolf Therapeutics Reports Q2 EPS of -$0.40, Beating Estimates - AInvest
Werewolf Therapeutics Faces Regulatory and Financial Challenges Amid FDA Disruptions - TipRanks
Is Werewolf Therapeutics Inc. in a bullish channel2025 Dividend Review & Free Risk Controlled Daily Trade Plans - sundaytimes.kr
Werewolf Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Werewolf Reports No Revenue in Fiscal Q2 - The Motley Fool
Werewolf Therapeutics, Inc. SEC 10-Q Report - TradingView
Werewolf Therapeutics: Capitalizing on Immuno-Oncology Innovation with a Strategic Path to Commercialization - AInvest
Cancer Drug Developer Werewolf Sets Q4 Melanoma Trial Readout, Unveils New Prostate Cancer Program - Stock Titan
Why Werewolf Therapeutics Inc. is moving todayJuly 2025 Closing Moves & Safe Entry Point Identification - Newser
Using economic indicators to assess Werewolf Therapeutics Inc. potential2025 Bull vs Bear & Precise Swing Trade Entry Alerts - Newser
Relative strength of Werewolf Therapeutics Inc. in sector analysisJuly 2025 Big Picture & Safe Entry Momentum Tips - Newser
Key metrics from Werewolf Therapeutics Inc.’s quarterly dataQuarterly Trade Summary & Trade Opportunity Analysis Reports - Newser
Published on: 2025-08-13 22:40:57 - 선데이타임즈
Understanding Werewolf Therapeutics Inc.’s price movementMarket Rally & Free Community Supported Trade Ideas - Newser
Analyzing Werewolf Therapeutics Inc. with risk reward ratio chartsAI-Based Signal Detection for Active Traders - Newser
Visual analytics tools that track Werewolf Therapeutics Inc. performanceQuarterly Earnings Summary & Community Supported Trade Ideas - Newser
Analyzing Werewolf Therapeutics Inc. with multi timeframe chartsStrong Buy Opportunity with Volume Support - Newser
How institutional ownership impacts Werewolf Therapeutics Inc. stockLong Term Stock Planner with Safety Checks - Newser
Short interest data insights for Werewolf Therapeutics Inc.Free Smart Allocation Stock Pick Insights - Newser
Strategies to average down on Werewolf Therapeutics Inc.Free Swing Trade Entry With Volume Triggers - Newser
Using Python tools to backtest Werewolf Therapeutics Inc. strategiesLong-Term Allocation Strategy Summary Breakdown - Newser
Full technical analysis of Werewolf Therapeutics Inc. stockBuy Zone Strategy with Pattern Recognition - Newser
Short Term Charts Align With Long Term Uptrend in Werewolf Therapeutics Inc.AI Driven Buy Alert Trade Blueprint Released - beatles.ru
Why Werewolf Therapeutics Inc. stock attracts strong analyst attentionDividend Strategy Summary With 10-Year Outlook - Newser
0.41%
0.88%
자본화:
|
볼륨(24시간):